Literature DB >> 4020380

Tryptophan hydroxylase activity in the brains of controls and parkinsonian patients.

M Sawada, T Nagatsu, I Nagatsu, K Ito, R Iizuka, T Kondo, H Narabayashi.   

Abstract

The activity of tryptophan hydroxylase was measured in nine regions of human brains from controls and patients with Parkinson's disease, striatonigral degeneration, Shy-Drager syndrome and progressive supranuclear palsy by high performance liquid chromatography with fluorescence detection. The regional distribution of the enzyme activity in control brains was similar to that of serotonergic neurons; relatively high activity was found in the raphe nucleus, locus coeruleus and substantia nigra. The activity in the thalamus in Parkinson's disease and that in the locus coeruleus, raphe nucleus and substantia nigra in striato-nigral degeneration were significantly lower than that of controls (p less than 0.05). In most other brain regions in parkinsonian patients the activity was relatively lower than that of controls except the caudate nucleus and nucleus accumbens where the activity was relatively higher than that of controls. Marked decrease in the enzyme activity in various brain regions was observed in striato-nigral degeneration, Shy-Drager syndrome, and progressive supranuclear palsy. These results suggest that the activity of tryptophan hydroxylase in serotonergic neurons is reduced in the brains of parkinsonian patients and of patients with degenerative nervous diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020380     DOI: 10.1007/bf01260420

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  12 in total

1.  CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.

Authors:  P Riederer; W D Rausch; W Birkmayer; K Jellinger; D Seemann
Journal:  J Neural Transm Suppl       Date:  1978

2.  The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

Authors:  K G Lloyd; L Davidson; O Hornykiewicz
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

3.  Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.

Authors:  P L McGeer; E G McGeer
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

4.  Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain.

Authors:  P A Friedman; A H Kappelman; S Kaufman
Journal:  J Biol Chem       Date:  1972-07-10       Impact factor: 5.157

5.  Enzymic studies on the biosynthesis of serotonin in mammalian brain.

Authors:  A Ichiyama; S Nakamura; Y Nishizuka; O Hayaishi
Journal:  J Biol Chem       Date:  1970-04-10       Impact factor: 5.157

6.  Further studies on tryptophan hydroxylase in rat brainstem and beef pineal.

Authors:  E Jequier; D S Robinson; W Lovenberg; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

7.  Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain.

Authors:  T Nagatsu; T Kato; Y Numata; K Ikuta; M Sano
Journal:  Clin Chim Acta       Date:  1977-03-01       Impact factor: 3.786

8.  Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay.

Authors:  T Nagatsu; T Yamaguchi; T Kato; T Sugimoto; S Matsuura; M Akino; I Nagatsu; R Iizuka; H Narabayashi
Journal:  Clin Chim Acta       Date:  1981-02-05       Impact factor: 3.786

9.  [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

Authors:  H BERNHEIMER; W BIRKMAYER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1961-10-15

10.  Effects of tyrosine administration on serum biopterin in normal controls and patients with Parkinson's disease.

Authors:  T Yamaguchi; T Nagatsu; T Sugimoto; S Matsuura; T Kondo; R Iizuka; H Narabayashi
Journal:  Science       Date:  1983-01-07       Impact factor: 47.728

View more
  5 in total

Review 1.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

2.  Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.

Authors:  Karl Strecker; Florian Wegner; Swen Hesse; Georg-Alexander Becker; Marianne Patt; Philipp M Meyer; Donald Lobsien; Johannes Schwarz; Osama Sabri
Journal:  J Neurol       Date:  2010-07-21       Impact factor: 4.849

3.  Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease.

Authors:  Donald M Kuhn; Catherine E Sykes; Timothy J Geddes; Karen L Eskow Jaunarajs; Christopher Bishop
Journal:  J Neurochem       Date:  2010-12-13       Impact factor: 5.372

4.  Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brain of anorexia nervosa.

Authors:  Y Hirata; M Sawada; M Minami; H Arai; R Iizuka; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 5.  Calmodulin and Its Binding Proteins in Parkinson's Disease.

Authors:  Anastasiia Bohush; Wiesława Leśniak; Serge Weis; Anna Filipek
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.